` Comparison: NYKD, AMGN - Alpha Spread

N
NYKD
vs
AMGN

Over the past 12 months, NYKD has underperformed AMGN, delivering a return of -52% compared to the AMGN's 8% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NYKD
AMGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

N
NYKD Intrinsic Value
4.05 NOK
Undervaluation 56%
Intrinsic Value
Price
AMGN Intrinsic Value
281.18 USD
Overvaluation 5%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
N
Nykode Therapeutics ASA
OSE:NYKD
1.8 NOK
Amgen Inc
NASDAQ:AMGN
296.45 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NYKD, AMGN

NYKD
AMGN
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
N
Nykode Therapeutics ASA
Revenue
Amgen Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
NYKD, AMGN

NYKD
AMGN
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
N
Nykode Therapeutics ASA
OSE:NYKD
Amgen Inc
NASDAQ:AMGN
What is Free Cash Flow?

Gross Margin

NYKD
0%
AMGN
69.7%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

Operating Margin

NYKD
-512.8%
AMGN
31.3%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

Net Margin

NYKD
-322.5%
AMGN
19%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

FCF Margin

NYKD
-607.8%
AMGN
34.4%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

ROE

NYKD
-17.3%
AMGN
99.1%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

ROA

NYKD
-15%
AMGN
7.4%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

ROIC

NYKD
-80.7%
AMGN
13.8%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

ROCE

NYKD
-25.6%
AMGN
16%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Amgen Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
NYKD, AMGN

Loading

Performance Gap
NYKD, AMGN

Loading
NYKD
AMGN
Difference
www.alphaspread.com

Performance By Year
NYKD, AMGN

Loading
NYKD
AMGN
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NYKD to other stocks
Unlock Full Access to Alpha Spread
Create Free Account